CIK 0001504776 · Large accelerated filer
Warby Parker Inc.
Sign in to watch- Ticker
- WRBY
- Exchange
- NYSE
- Industry
- Ophthalmic Goods
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- operating
- EIN
- 800423634
- Phone
- (646) 847-7215
- Business address
- 233 SPRING STREET, 6TH FLOOR EAST, NEW YORK, NY, 10013
- Former names
- JAND, Inc.
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $7,861,485
- in 5 filings, $7.9M under 10b5-1 plans
Net −$7,861,485. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-07-06 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −9,200 | 3,220,450 | ||
| 2026-07-01 | Raider Jeffrey Jacob Director | Sale 10b5-1 | −22,500 | $29.72 | $669K | 435,201 |
| 2026-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Conversion 10b5-1 | +213,746 | 273,333 | ||
| 2026-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Sale 10b5-1 | −242,221 | $29.69 | $7.2M | 31,112 |
| 2026-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Stock Option (Right to Buy) 10b5-1 | −117,221 | 593,538 | ||
| 2026-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Option exercise · Class B Common Stock 10b5-1 | +117,221 | $3.83 | $449K | 4,769,150 |
| 2026-07-01 | Gilboa David Abraham Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −213,746 | 4,555,404 | ||
| 2026-07-01 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion 10b5-1 | +189,320 | 248,779 | ||
| 2026-07-01 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −217,667 | $29.61 | $6.4M | 31,112 |
| 2026-07-01 | Blumenthal Neil Harris Co-Chief Executive Officer | Conversion · Class B Common Stock 10b5-1 | −189,320 | 3,229,650 | ||
| 2026-06-29 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise 10b5-1 | +36,300 | 95,759 | ||
| 2026-06-29 | Blumenthal Neil Harris Co-Chief Executive Officer | Sale 10b5-1 | −36,300 | $30.04 | $1.1M | 59,459 |
| 2026-06-29 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Class B Common Stock 10b5-1 | −36,300 | 3,418,970 | ||
| 2026-06-18 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Stock Option (Right to Buy) | −200,000 | 510,759 | ||
| 2026-06-18 | Blumenthal Neil Harris Co-Chief Executive Officer | Option exercise · Class B Common Stock | +200,000 | $3.83 | $766K | 3,177,577 |
| 2026-06-16 | Briggs Teresa Director | Sale 10b5-1 | −3,092 | $25.41 | $79K | 50,791 |
| 2026-06-16 | Briggs Teresa Director | Sale 10b5-1 | −1,908 | $26.79 | $51K | 48,883 |
| 2026-06-12 | Moon Youngme E Director | Sale | −10,000 | $26.53 | $265K | 26,061 |
| 2026-06-08 | Raider Jeffrey Jacob Director | Grant or award | +9,004 | 457,701 | ||
| 2026-06-08 | Hunt Andrew Director | Grant or award | +12,005 | 1,941,236 |
Page 3 of 20 · 390 trades